Migraine Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2605 | Report Format : | Status : Upcoming |

Abstract

Global Migraine Drugs Market: Overview

About 12–14% of people around the world suffer from a Migraine; it is a type of a headache. According to regional and international rules, migraine is classified by the nature of the attack and its frequency into a chronic migraine and episodic migraine. Prophylactic and abortive are 2 treatments available for the relief of this headache type. Prophylactic treatment is offered to patients suffering from a chronic migraine in order to avoid migraine attacks utilizing medications like topiramate, botulinum toxin, and others. Abortive treatment is offered to terminate severe migraine attack and includes medication like ergot alkaloids, triptans, and others.

Global Migraine Drugs Market: Growth Factors

The increasing awareness regarding a migraine and various options available for its treatment are the major factors boosting the growth of the global migraine drugs market. A number of organizations including the American Headache and Migraine Association are taking efforts to spread awareness about a migraine and hence coming up with programs and providing support to patients so as to spread awareness regarding the disease and further disorders related to a headache. Due to the increasing number of migraine incidences and rising number of unmet needs in the global migraine drugs market, a number of companies are planning to invest in the migraine drugs R&D. This, in turn, is anticipated to propel the global migraine drugs market growth in the near future.

Global Migraine Drugs Market: Segmentation

The global migraine drugs market is segmented on the basis of treatment type, route of administration, and distribution channel. On the basis of treatment type, the global migraine drugs market is segmented as prophylactic and abortive. The prophylactic treatment segment is further sub-segmented as topiramate, botulinum toxin, and others. The abortive treatment segment is further sub-segmented as ergot alkaloids, triptans, and others. On the basis of route of administration, the global market is classified as injectable, oral, and others. The others segment is further sub-segmented as transdermal patches and nasal sprays. On the basis of the distribution channel, the global migraine drugs market is diversified as hospital pharmacies, retail pharmacies, and others.

Global Migraine Drugs Market: Regional Analysis

The Asia Pacific is anticipated to dominate the global migraine drugs market and is further expected to continue this trend in the near future. This high growth is mainly owing to the increasing number of people having from a migraine and rising public awareness of the disease in this region. In addition, China and India are the major developing countries contributing to the global migraine drugs market growth in the Asia Pacific region; this is mainly due to the high occurrence of a migraine in these countries. Rising focus on niche products and their launches along with high penetration of novel drug manufacturers will further have a positive impact on the growth of the global migraine drugs market in the near future.

Global Migraine Drugs Market: Competitive Players

Some of the major players in the global migraine drugs market include Endo, Allergan, Impax Laboratories, Glaxo Smith Kline, Astellas, Amgen, Bayer, AstraZeneca, Dr. Reddy's Laboratories, Zogenix, CoLucid, Eli Lilly, Eisai, IntelGenx, Ethypharm, and Klaria. Other key players dominating the global market are Johnson & Johnson, Luitpold Pharmaceuticals, Kowa Pharmaceuticals America, Merck, Meda, Pfizer, OptiNose, Raptor, Pozen, SUDA, RedHill, TG Therapeutics, Teva, Winston Pharmaceuticals, and NValeant.

Global Migraine Drugs Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Peptide and Anticoagulant Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3130 | Report Format:

Global Peptide and Anticoagulant Drugs Market: Overview Peptides anticoagulant drugs are likely to have a wide range of applications in treating several diseases for example osteoporosis, cancer, cardiovascular, diabetes, and coagulation disorders. Peptides are basically molecules that are univ...Read More

Crohn’s Disease Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3033 | Report Format:

Global Crohns Disease Market: Overview An inflammatory disease of bowel affecting any part of the Gastro-Intestinal Tract (GI Tract) is termed as Crohns disease. It is classified into a segment of chronic disease. Crohns disease is considered to impact nearly every part of an individuals life, a...Read More

Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3024 | Report Format:

Global Anti-Neoplastic Agents Market: Overview Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of canc...Read More

Kidney Fibrosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2989 | Report Format:

Global Kidney Fibrosis Treatment Market: Overview Fibrosis is the growth of extreme connective tissue owing to some injury or some disease. Disease in the kidney can cause kidney fibrosis. In this state, the kidneys fail to work properly which gradually leads to severe conditions. Kidney transpl...Read More

Oncology Based In-vivo CRO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2982 | Report Format:

Global Oncology Based In-vivo CRO Market: Overview CRO basically stands for contract research organization which presents research services to a pharmaceutical, biotechnology, and medical devices key players on the basis of the contract. CRO offers services such as clinical research, biologic as...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.